Elicera Therapeutics AB (publ) ELIC

Updated: 11 Aug 2026

First North | Biotech | Biotech / Immuno-oncology

No signal published yet

We already track Elicera Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Elicera Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
First North
Type
Biotech
Sector
Biotech / Immuno-oncology
We're already tracking Elicera Therapeutics AB (publ) — here are the latest events we've registered

Recent News

  • On August 11, 2026, Elicera announced that the final patient was treated in the Phase I part of the CARMA study evaluating ELC-301. Updated data showed tumor responses in 10 of 11 evaluated patients, with six achieving a complete metabolic response.

What Firelda Watch includes for Elicera Therapeutics AB (publ)

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Elicera Therapeutics AB (publ) will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Biotech

More companies in this sector

Want to follow Elicera Therapeutics AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Elicera Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Elicera Therapeutics AB (publ) ELIC
Elicera Therapeutics — follow and we'll monitor it
Follow Elicera Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.